2023 International Congress Archives - Page 15 of 186

Analysis of excessive daytime sleepiness and clinical findings in Parkinson’s disease

S. Ueno, N. Nishikawa, H. Takeshige-Amano, T. Ogawa, D. Kamiyama, A. Shindo, K. Shiina, K. Ishikawa, T. Tsunemi, M. Yoshitake, C. Abe, S. Saiki, T. Hatano, N. Hattori (Tokyo, Japan)
Analysis of functional connectivity using machine learning and deep learning in EEG data from patients with focal dystonia

C. Alves, A. Paulo, D. de Faria, J. Sato, S. Azevedo Silva, V. Borges, H. Ferraz, F. Rodrigues, C. Thielemann, P. Carvalho Aguiar (Sao Carlos Pinhal, Brazil)
Analysis of levodopa use in patients with Parkinson’s Disease during pregnancy: a systematic review of the last twenty years

R. Albuquerque, E. Almeida, G. Herwig, G. Bolner, G. Maia, G. Mantovani, MF. Felippe, V. Müller (Porto Alegre, Brazil)
Analysis of subthalamic-nuclei deep brain stimulation using radiomic feature-manifestations: a quantitative approach

V. Rama Raju (Hyderabad, India)
Analysis of the network of genes related to Parkinson’s and identification of key proteins

H. Ghapani, D. Morshedi, S. Parsafar, F. Aliakbari (Tehran, Islamic Republic of Iran)
Analysis of the relationship between acoustic measures and VHI score

Y. Manor, Y. Kochetkov, Y. Hauptman, D. Shpunt, A. Zait, T. Gurevich (Tel Aviv, Israel)
Analysis of the therapeutic potential of c-Abl inhibition in Multiple System Atrophy

M. Werner, E. Bertin, A. Simmonet, E. Noé, P. Fernagut, J. Molina, K. Lowe, E. Bezard, J. Kordower (Atlanta, USA)
Analysis of the therapeutic potential of IkT-148009 in Parkinson’s disease

M. Werner, R. Rush, T. Kelly, S. Singh, S. Kruger, C. Olanow, A. Mcgarry (Atlanta, USA)
Analysis of α-Synuclein Seed Amplification Assay in Carriers of GBA and LRRK2 Pathogenic Variants

K. Fraser, A. Mirelman, O. Mabrouk, N. Omer, L. Concha-Marambio, T. Gurevich, A. Bar Shira, M. Gana-Weisz, O. Goldstein, A. Orr-Urtreger, M. Kestenbaum, J. Cedarbaum, T. Dam, J. Shirvan, N. Giladi, D. Graham, R. Alcalay, A. Thaler (Cambridge, USA)
Angiotensin II Type 1 (AT1) receptor antagonists as potential candidates for anxiety treatment in Parkinson’s Disease

S. Bordet, L. Grasso, L. Udovin, G. Chevalier, M. Otero-Losada, F. Capani, S. Perez-Lloret (Buenos Aires, Argentina)